Curcumin inhibits the activation of immunoglobulin e-mediated mast cells and passive systemic anaphylaxis in mice by reducing serum eicosanoid and histamine levels

Biomolecules and Therapeutics

Volumn 22, Issue 1, 2014, Pages 27-34

  Li, Xian ^a   Lu, Yue ^b   Jin, Ye ^a   Son, Jong Keun ^a   Lee, Seung Ho ^a   Chang, Hyeun Wook ^a  

^a Yeungnam University   (South Korea)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Curcumin; Mast cell; Mitogen activated protein kinase; Passive systemic anaphylaxis

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CALCIUM ION; CURCUMIN; CYCLOOXYGENASE 2; HISTAMINE; ICOSANOID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOTRIENE C4; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C GAMMA1; PROSTAGLANDIN D2; PROTEIN KINASE SYK;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAST CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SYSTEMIC ANAPHYLAXIS;

EID: 84893089979     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2013.092     Document Type: Article

References (39)

1. Ammon, H. P. and Wahl, M. A. (1991) Pharmacology of Curcuma longa. Planta Med. 57, 1-7
2. Ashraf, M., Murakami, M. and Kudo I. (1996) Cross-linking of the highaffinity IgE receptor induces the expression of cyclo-oxygenase 2 and attendant prostaglandin generation requiring interleukin 10 and interleukin 1 beta in mouse cultured mast cells. Biochem. J. 320, 965-973
3. Avis, I., Hong, S. H., Martinez, A., Moody, T., Choi, Y. H., Trepel, J., Das, R., Jett, M. and Mulshine, J. L. (2001) Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J. 15, 2007-2009
4. Cho, J. W., Lee, K. S. and Kim, C. W. (2007) Curcumin attenuates the expression of IL-1β, IL-6, and TNF-α as well as cyclin E in TNF- α-treated HaCaT cells; NF-κB and MAPKs as potential upstream targets. Int. J. Mol. Med. 19, 469-474
5. Choi, Y. H., Yan, G. H., Chai, O. H. and Song, C. H. (2010) Inhibitory effects of curcumin on passive cutaneous anaphylactoid response and compound 48/80-induced mast cell activation. Anat. Cell Biol. 43, 36-43
6. Chun, K. S., Keum, Y. S., Han, S. S., Song, Y. S., Kim, S. H. and Surh, Y. J. (2003) Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal regulated kinase activity and NF-κB activation. Carcinogenesis 24, 1515-1524
7. Ciprandi, G., Tosca, M. A., Cosentino, C., Riccio, A. M., Passalacqua, G. and Canonica, G. W. (2003) Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules. J. Allergy Clin. Immunol. 112, S78-82
8. Fischer, L., Poeckel, D., Buerkert E., Steinhilber, D. A D, Werz, O. (2005) Inhibitors of actin polymerization stimulate arachidonic acid release and 5-lipoxygenase activation by upregulation of Ca2+ mobilisation in polymorphonuclear leukocytes involving Src family kinases. Biochim. Biophys. Acta 1736, 109-119
9. Gijon, M. A. and Leslie, C. C. (1999) Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J. Leukoc. Biol. 65, 330-336
10. Hong, J., Bose, M., Ju, J., Ryu, J. H., Chen, X., Sang, S., Lee, M. J. and Yang, C. S. (2004) Modulation of arachidonic acid metabolism by curcumin and related β-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25, 1671-1679
11. Huang, M. T., Lysz, T., Ferraro, T., Abidi, T. F., Laskin, J. D. and Conney, A. H. (1991) Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51, 813-819
12. Hwang, S. L., Li, X., Lu, Y., Jin, Y., Jeong, Y. T., Kim, Y. D., Lee, I. K., Taketomi, Y., Sato, H., Cho, Y. S., Murakami, M. and Chang, H. W. (2013) AMP-activated protein kinase negatively regulates FcεRImediated mast cell signaling and anaphylaxis in mice. J. Allergy Clin. Immunol. 132, 729-736
13. Kemp, S. F. and Lockey, R. F. (2002) Anaphylaxis: a review of causes and mechanisms. J. Allergy Clin.Immunol. 110, 341-348
14. Kiuchi, F., Goto, Y., Sugimoto, N., Akao, N., Kondo, K. and Tsuda, Y. (1993) Nematocidal activity of turmeric: synergistic action of curcuminoids. Chem. Pharm. Bull. 41, 1640-1643
15. Kudo, I. and Murakami, M. (1999) Diverse functional coupling of prostanoid biosynthetic enzymes in various cell types. Adv. Exp. Med. Biol. 469, 29-35
16. Lee, J. H., Kim, J. W., Ko, N. Y., Mun, S. H., Her, E., Kim, B. K., Han, J. W., Lee, H. Y, Beaven, M. A., Kim, Y. M. and Choi, W. S. (2008) Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk. J. Allergy Clin. Immunol. 121, 1225-1231
17. Lee, K. W., Kim, J. H, Lee, H. J and Surh, Y. J. (2005) Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells. Antioxid. Redox. Signal. 7, 1612-1620
18. Lin, L. L., Wartmann, M., Lin, A. Y., Knopf, J. L., Seth, A. and Davis, R. J. (1993) cPLA2 is phosphorylated and activated by MAP kinase. Cell 72, 269-278
19. Lu, Y., Suh, S. J., Li, X., Hwang, S. L., Li, Y., Hwangbo, K., Park, S. J., Murakami, M., Lee, S. H., Jahng, Y., Son, J. K., Kim, C. H. and Chang, H. W. (2012) Citreorosein, a naturally occurring anthraquinone derivative isolated from Polygoni cuspidati radix, attenuates cyclooxygenase-2-dependent prostaglandin D2 generation by blocking Akt and JNK pathways in mouse bone marrow-derived mast cells. Food Chem. Toxicol. 50, 913-919
20. Lu, Y., Yang, J. H., Li, X., Hwangbo, K., Hwang, S. L., Taketomi, Y., Murakami, M., Chang, Y. C., Kim, C. H., Son, J. K and Chang, H. W. (2011) Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation. Biochem. Pharmacol. 82, 1700-1708
21. Mazuc, E., Villoutreix, B. O., Malbec, O., Roumier, T., Fleury, S., Leonetti, J. P., Dombrowicz, D., Daëron, M., Martineau, P. and Dariavach, P. (2008) A novel druglike spleen tyrosine kinase binder prevents anaphylactic shock when administered orally. J Allergy Clin. Immunol. 122, 188-194
22. Mehrabian, M. and Allayee, H. (2003) 5-lipoxygenase and atherosclerosis. Curr. Opin Lipidol. 14, 447-457
23. Moon, T. C., Murakami, M., Ashraf, M. D., Kudo, I. and Chang H. W. (1998) Regulation of cyclooxygenase-2 and endogenous cytokine expression by bacterial lipopolysaccharide that acts in synergy with c-kit ligand and Fc epsilon receptor I crosslinking in cultured mast cells. Cell. Immunol. 185, 146-152
24. Murphy, R. C. and Gijon, M. A. (2007) Biosynthesis and metabolism of leukotrienes. Biochem. J. 405, 379-395
25. Ram, A., Das, M. and Ghosh, B. (2003) Curcumin attenuates allergeninduced airway hyperresponsiveness in sensitized guinea pigs. Biol. Pharm. Bull. 26, 1021-1024
26. Reddy, S. T., Wadleigh, D. J. and Herschman, H. R. (2000) Transcriptional regulation of the cyclooxygenase-2 gene in activated mast cells. J. Biol. Chem. 275, 3107-3113
27. Ricciotti, E. and FitzGerald, G. A. (2011) Prostaglandins and Inflammation. Arterioscler. Thromb. Vasc. Biol. 31, 986-1000
28. Ruzza, P., Biondi, B. and Calderan, A. (2009) Therapeutic prospect of Syk inhibitors. Expert Opin. Ther. Pat. 19, 1361-1376
29. Simons, F. E. (2008) Anaphylaxis. J. Allergy Clin. Immunol. 121, S402-S407
30. Siraganian, R. P. (2003) Mast cell signal transduction from the highaffinity IgE receptor. Curr. Opin. Immunol. 15, 639-646
31. Surh, Y. J, Chun, K. S., Cha, H. H., Han, S. S., Keum, Y. S., Park, K. K. and Lee, S. S (2001). Molecular mechanisms underlying chemopreventive activities of anti-inflamatory phytochemicals: downregulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 480-481, 243-268
32. Suzuki, M., Nakamura, T., Iyoki, S., Fujiwara, A., Watanabe, Y., Mohri, K., Isobe, K., Ono, K. and Yano, S. (2005) Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. Biol. Pharm. Bull. 28, 1438-1443
33. Tak, P. P., and Firestein, G. S. (2000) NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 107, 7-11
34. Wershil, B. K., Mekori, Y. A., Murakami, T. and Galli, S. J. (1987) 125Ifibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J. Immunol. 139, 2605-2614
35. Werz, O. (2002) 5-lipoxygenase: cellular biology and molecular pharmacology. Curr. Drug Targets Inflamm. Allergy 1, 23-44
36. Werz, O. and Steinhilber, D. (2006) Therapeutic options for 5-lipoxygenase inhibitors. Pharmacol. Ther. 112, 701-718
37. Yano, S., Terai, M., Shimizu, K. L., Futagami, Y., Sekine, T., Takamoto, K., Saito, K., Ueno, K. and Watanabe, K. (2000) Antiallergic activity of Curcuma longa. (II). Features of inhibitory actions on histamine release from mast cells. Nat. Med. 54, 325-329
38. Yamaguchi, M., Sayama, K., Yano, K., Lantz, C. S., Noben-Trauth N., Ra C., Costa J. J. and Galli, S. J. (1999) IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. J. Immunol. 162, 5455-5465
39. Yu, L. L., Dai, N., Yu, H.G., Sun, L. M. and Si, J. M. (2010) Akt associates with nuclear factor kappaB and plays an important role in chemoresistance of gastric cancer cells. Oncol. Rep. 24, 113-119.